• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. XIENCE SKYPOINT¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. XIENCE SKYPOINT¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 1804300-33
Medical Device Problem Codes Entrapment of Device (1212); Difficult to Advance (2920); Device Dislodged or Dislocated (2923); Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/15/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the procedure was to treat the proximal left anterior descending (lad) coronary artery with moderate calcification and moderate tortuosity.The 3.0x33 mm xience skypoint stent delivery system (sds) was being advanced when the engagement of the guiding catheter became unstable and resistance was noted with the guiding catheter during advancement.While pushing and pulling the sds around the guiding catheter with resistance, the stent hit the edge of the guiding catheter causing stent deformation and displacement on the balloon.The stent remained on the balloon and the entire sds was ultimately retrieved via snare, using a femoral approach.A non-abbott stent was used to complete the procedure.There were no adverse patient sequela and there was no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Additional Manufacturer Narrative
The device was not returned for analysis.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot specific issue.A conclusive cause for the reported difficulties cannot be determined; however, the subsequent treatment appears to be related to the operational context of the procedure.It was reported that the stent delivery system (sds) met resistance with a guiding catheter, resulting in the stent became deformed and displaced on the balloon.Factors that may contribute to difficulty advancing the sds through the guiding catheter include, but are not limited to, inner diameter of the catheter, system profile, guidewire movement (im collapse), inadequate deliverability, or challenging anatomy.Based on the information provided and because the device was not returned for analysis, it is unknown what may have caused the reported difficulties during advancement.In addition, it was reported that the sds became deformed and displaced.In this case, it is possible the manipulation of the sds, when resistance was met, contributed to the reported material deformation and device dislodged or dislocated.Additionally, it is likely that the interaction with the guiding catheter contributed to the entrapment.There is no indication of a product quality issue with respect to manufacture, design, or labeling; therefore, no product-related corrective action will be implemented in this case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT¿
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key20855499
Report Number2024168-2024-14314
Device Sequence Number15661276
Product Code NIQ
UDI-Device Identifier08717648233272
UDI-Public(01)08717648233272(17)261112(10)3111641
Combination Product (Y/N)Y
Initial Reporter CountryJA
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/14/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number1804300-33
Device Catalogue Number1804300-33
Device Lot Number3111641
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/18/2024
Supplement Date Received by Manufacturer01/13/2025
Initial Report FDA Received Date12/05/2024
Supplement Report FDA Received Date01/14/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/13/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
UNSPECIFIED GUIDING CATHETER
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-